LGC launched two new banned substance testing and certification programs: Informed Manufacturer and Informed Ingredient, targeting ingredients for sports nutrition products and facilities that manufacture sports supplements.
LGC (Lexington, KY) launched two new banned substance testing and certification programs: Informed Manufacturer and Informed Ingredient, targeting ingredients for sports nutrition products and facilities that manufacture sports supplements. These ingredients and facilities were previously certified under Informed Sport and Informed Choice, but now they have their own identifiable marks. All testing is conducted at LGC’s ISO 17025 accredited laboratories.
“We are excited to announce the two newest certification programs in our INFORMED family, Informed Ingredient and Informed Manufacturer,” said LGC business development director, Paul Klinger, in a press release. “The programs are a perfect opportunity for ingredient suppliers and manufacturing facilities looking to take an extra step in quality assurance and are founded upon LGC’s more than 50-years of anti-doping experience.”
Informed Ingredient provides banned substance testing and certification for raw materials and ingredients in sports nutrition products. Certified ingredients must meet strict quality control standards and are screened for more than 250+ banned substances to parts-per-billion accuracy. Tested lots of certified ingredients are published on the program’s website.
Informed Manufacturer is a quality assurance program that helps to minimize the risk of banned substance contamination within facilities that manufacture and supply sports nutrition products and ingredients. Certification is attained through testing swabs of various locations throughout the facility and a thorough review of SOPs. Third-party manufacturers can utilize certification and the new logo to communicate to that their facility met high-quality control standards and has been assessed to minimize contamination risk.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.